Jane Street Group, LLC Iovance Biotherapeutics, Inc. Call Options Transaction History

Jane Street Group, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 17, 2022	BUY	$12.38 - $19.1 $919,834 - $1.42 Million	74,300 Added 62.38%	193,400 $3.22 Million
Q4 2021 Feb 15, 2022	BUY	$16.55 - $27.63 $643,795 - $1.07 Million	38,900 Added 48.5%	119,100 $2.27 Million
Q3 2021 Nov 16, 2021	SELL	$20.35 - $26.63 $1.76 Million - $2.3 Million	-86,500 Reduced 51.89%	80,200 $1.98 Million
Q2 2021 Aug 16, 2021	BUY	$16.33 - $33.07 $1.92 Million - $3.89 Million	117,600 Added 239.51%	166,700 $4.34 Million
Q1 2021 May 18, 2021	SELL	$28.67 - $52.59 $2.1 Million - $3.85 Million	-73,200 Reduced 59.85%	49,100 $1.56 Million
Q4 2020 Feb 17, 2021	BUY	$28.04 - $50.26 $1.89 Million - $3.38 Million	67,300 Added 122.36%	122,300 $5.68 Million
Q3 2020 Nov 17, 2020	SELL	$27.75 - $36.3 $2.43 Million - $3.17 Million	-87,400 Reduced 61.38%	55,000 $1.81 Million
Q2 2020 Aug 17, 2020	BUY	$27.21 - $41.0 $1.12 Million - $1.69 Million	41,200 Added 40.71%	142,400 $3.91 Million
Q1 2020 May 15, 2020	BUY	$19.54 - $38.85 $1.98 Million - $3.93 Million	101,200 New	101,200 $3.03 Million

320

238M

1.27M

1.68M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.74B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.